ImpediMed (IPD) Stock Overview

ImpediMed Limited, a medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema, and deliver snapshot of fluid status and tissue composition; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia.

IPD Stock Information

Symbol

IPD

Address

50 Parker CourtPinkenba, QLD 4008Australia

Founded

Trading hours

10:00 AM - 4:00 PM AEST

Website

https://www.impedimed.com

Country

🇦🇺 Australia

Phone Number

61 7 3860 3700

ImpediMed (IPD) Price Chart

ImpediMed Overview: Key Details and Summary

Stock data	2023	Change
Price	$0.03315021784428869	N/A
Market Cap	$59.68M	N/A
Shares Outstanding	1.80B	7.23%
Employees	76.00	N/A
Shareholder Equity	60.88M	19.27%

Valuation	2023	Change
P/S Ratio	7.84	N/A
P/B Ratio	0.98	N/A

Growth	2023	Change
Return on Equity	-0.2280	N/A

Earnings	2023	Change
Revenue	$7.61M	N/A
Earnings	-$13.88M	N/A
Gross Margin	0.8626	N/A
Operating Margin	-2.04	N/A
Net income margin	-1.82	N/A

Financial Strength	2023	Change
Total Assets	$46.50M	N/A
Total Debt	$978.95K	N/A
Cash on Hand	$30.92M	N/A
Debt to Equity	0.0873	-13.94%
Cash to Debt	$31.59	N/A
Current Ratio	$8.88	37.88%